These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10506701)

  • 21. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.
    Fontanini G; Macchiarini P; Pepe S; Ruggiero A; Hardin M; Bigini D; Vignati S; Pingitore R; Angeletti CA
    Cancer; 1992 Sep; 70(6):1520-7. PubMed ID: 1355398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma.
    Situ D; Long H; Lin P; Zhu Z; Wang J; Zhang X; Xie Z; Rong T
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1213-9. PubMed ID: 20127360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non-small cell lung cancer.
    Oyama T; Mitsudomi T; Mizoue T; Ohgami A; Osaki T; Nakanishi R; Yasumoto K
    Surg Oncol; 1995; 4(2):83-9. PubMed ID: 7551263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
    J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.
    Ramnath N; Hernandez FJ; Tan DF; Huberman JA; Natarajan N; Beck AF; Hyland A; Todorov IT; Brooks JS; Bepler G
    J Clin Oncol; 2001 Nov; 19(22):4259-66. PubMed ID: 11709570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancer.
    Dworakowska D; Gózdz S; Jassem E; Badzio A; Kobierska G; Urbaniak A; Skokowski J; Damps I; Jassem J
    Lung Cancer; 2002 Jan; 35(1):35-41. PubMed ID: 11750711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma.
    Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH
    Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
    Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
    Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of prognostic factors and PCNA expression for pulmonary metastatic tumors of colorectal carcinoma.
    Matsushima S; Yamamoto H; Suzuki S; Egami K; Yoshioka M; Yamada N; Tanaka S
    J Nippon Med Sch; 2000 Feb; 67(1):28-31. PubMed ID: 10777845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44V6 expression in human colorectal carcinoma.
    Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
    Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of different biomarkers in non-small cell lung cancer.
    Lavezzi AM; Santambrogio L; Bellaviti N; Biondo B; Nosotti M; Radice F; Matturri L
    Oncol Rep; 1999; 6(4):819-25. PubMed ID: 10373663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
    Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
    Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of proliferating cell nuclear antigen expression and prognosis in patients with renal cell carcinoma with pulmonary metastases.
    Gotoh A; Hanioka K; Shirakawa T; Wada Y; Gohji K; Okada H; Arakawa S; Kamidono S
    Int J Urol; 1998 May; 5(3):214-8. PubMed ID: 9624550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of human CD44v6 in non-small-cell lung cancer.
    Carbognani P; Spaggiari L; Romani A; Solli P; Corradi A; Cantoni AM; Petronini PG; Borghetti AF; Rusca M; Bobbio P
    Eur Surg Res; 1998; 30(6):403-8. PubMed ID: 9838232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of high expression of proliferating cell nuclear antigen in non-small cell lung cancer.
    Ye X; Ling B; Xu H; Li G; Zhao X; Xu J; Liu J; Liu L
    Medicine (Baltimore); 2020 Apr; 99(16):e19755. PubMed ID: 32311975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
    Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gallbladder, and its relationship to prognosis.
    Hanada K; Itoh M; Fujii K; Tsuchida A; Ishimaru S; Hirata M; Kajiyama G
    Scand J Clin Lab Invest; 1995 Aug; 55(5):377-82. PubMed ID: 8545595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS
    Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.